Ansbert Gadicke insider trades
Open-market stock purchases and sales by Ansbert Gadicke, Unknown at Aktis Oncology, Inc, from SEC Form 4 filings since Sep 30, 2010.
Track record: 0% of 11 scored buys are up 5% or more since purchase, averaging -42%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 12, 2026 | AKTS Aktis Oncology, Inc | Bought (not open market) | — |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc | Bought (not open market) | — |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc | Bought (not open market) | — |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc | Bought | $20M |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc | Bought (not open market) | — |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc | Bought (not open market) | — |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc | Bought (not open market) | — |
| Dec 4, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $80.7K |
| Dec 3, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $49.8K |
| Dec 2, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $52.8K |
| Dec 1, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $57.3K |
| Nov 28, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $20.1K |
| Nov 26, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $59.5K |
| Nov 25, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $39.1K |
| Nov 24, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $87K |
| Nov 21, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $53.4K |
| Nov 20, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $36.6K |
| Nov 19, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $62.3K |
| Nov 18, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $48.9K |
| Nov 17, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $54.2K |
| Nov 14, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $57.3K |
| Nov 13, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $89.1K |
| Nov 12, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $44.3K |
| Nov 11, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $63.6K |
| Nov 10, 2025 | HOWL Werewolf Therapeutics, Inc | Sold | $57.3K |
Companies traded
- AKTS Aktis Oncology, Inc: 1 buy, last Jan 12, 2026
- HOWL Werewolf Therapeutics, Inc: 1 buy, 29 sales, last Dec 4, 2025
- ITOS iTeos Therapeutics, Inc: 7 buys, 73 sales, last May 13, 2025
- TCRR Tcr2 Therapeutics Inc: 1 sale, last Jun 1, 2023
- ALVR Allovir, Inc: other filings, last Jul 28, 2022
- CGEM Cullinan Oncology, Inc: 1 buy, 38 sales, last Jun 22, 2022
- RPTX Repare Therapeutics Inc: 1 buy, 50 sales, last Jul 12, 2021
- HARP Harpoon Therapeutics, Inc: 50 sales, last Jun 2, 2021
- ONCR Oncorus, Inc: 2 buys, last Oct 6, 2020
- RDUS Radius Health, Inc: other filings, last Feb 17, 2017
- CHMA Chiasma, Inc: other filings, last Jun 9, 2016
- PETX Aratana Therapeutics, Inc: 1 sale, last Mar 7, 2014